BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18251181)

  • 1. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
    Ishii HH; Gobe GC; Ebihara Y
    Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
    Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y
    J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
    Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
    Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
    Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
    Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study.
    Gonda G; Bajtai A; Nagy P; Szántó I; Kiss J
    Hepatogastroenterology; 2004; 51(55):273-6. PubMed ID: 15011884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
    Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
    Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
    Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
    Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
    Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
    Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer.
    Inadomi T; Tan M; Suzuki H; Shigematsu C
    Eur J Dermatol; 1999; 9(3):214-7. PubMed ID: 10210788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
    Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
    Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers.
    Shiao YH; Palli D; Caporaso NE; Alvord WG; Amorosi A; Nesi G; Saieva C; Masala G; Fraumeni JF; Rice JM
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):631-3. PubMed ID: 10868700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
    Ishii HH; Gobé GC; Pan W; Yoneyama J; Ebihara Y
    J Gastroenterol Hepatol; 2002 Sep; 17(9):966-72. PubMed ID: 12167117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma.
    Niimi C; Goto H; Ohmiya N; Niwa Y; Hayakawa T; Nagasaka T; Nakashima N
    Am J Clin Pathol; 2002 Nov; 118(5):683-92. PubMed ID: 12428787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.